RE:RE:RE:RE:RE:Check out news today at PAILook, my point is that this ITSS is not the breakthrough product that some posters seem to imply it is. I believe ITSS will continue to be insignificant for GSI.V, and these posters are going to grow to be more insecure about GSI.V while ignoring the areas where GSI.V is actually strong in. It's also painful seeing bulls who are too high on confirmation bias. Here are the facts:
A fever is too non-specific to make a conclusion off, heck you could have a high enough body temperature to trigger false alarms just because it's summer. We have newer studies (e.g. this one
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms that sheds more light on asymptomatic spread of COVID, a stark difference from earlier last year when WHO stated asymptomatic spread was very rare. Now you have widespread vaccination coming up in the corner, and hypothetically these pharmaceutical companies can develop new vaccines for new variants in less than 100 days
(source: Pfizer CEO vows to speed up vaccine development to under 100 days to combat the 'high likelihood' that current COVID-19 shots will become ineffective). With that in mind, ask yourself why a business (likely already drowning in debt because of COVID) invest money into a product that is not supported by evidence?
Bottom-line is, there is no strong evidence to support it. For the record, I've been occasionally working part-time on weekends at a pharmacy throughout covid which has seen cases of COVID already, so believe me that I'd be open to measures that are actually effective. I already don't feel safe since I'm not getting my 2nd dose of the vaccine until MONTHS later since Canada really wants to bet on the vaccine effectiveness and turn us all into guinea pigs with these decision.
You're welcome to prove me wrong with actual evidence. The only way I see ITSS being largely successful is if the sales team convinces customers with car salesman talk.